John Lamont
John Lamont
Professor of Medicine, Harvard Medical School
Verified email at
Cited by
Cited by
Clostridium difficile More Difficult Than Ever
CP Kelly, JT LaMont
New England Journal of Medicine 359 (18), 1932-1940, 2008
Clostridium difficile colitis
CP Kelly, C Pothoulakis, JT LaMont
New England Journal of Medicine 330 (4), 257-262, 1994
Clostridium difficile Infection
DA Leffler, JT Lamont
New England Journal of Medicine 372 (16), 1539-1548, 2015
Choline, an essential nutrient for humans
SH Zeisel, KA Da Costa, PD Franklin, EA Alexander, JT Lamont, ...
The FASEB journal 5 (7), 2093-2098, 1991
Clostridium difficile Infection
CP Kelly, JT LaMont
Annual review of medicine 49 (1), 375-390, 1998
Saccharomyces boulardii Protease Inhibits the Effects of Clostridium difficile Toxins A and B in Human Colonic Mucosa
I Castagliuolo, MF Riegler, L Valenick, JT LaMont, C Pothoulakis
Infection and immunity 67 (1), 302-307, 1999
Mucin biophysics
R Bansil, E Stanley, JT LaMont
Annual review of physiology 57 (1), 635-657, 1995
Role of Gallbladder Mucus Hypersecretion in the Evolution of Cholesterol Gallstones: STUDIES IN THE PRAIRIE DOG
SP Lee, JT Lamont, MC Carey
The Journal of clinical investigation 67 (6), 1712-1723, 1981
Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers.
G Hecht, C Pothoulakis, JT LaMont, JL Madara
The Journal of clinical investigation 82 (5), 1516-1524, 1988
Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.
M Riegler, R Sedivy, C Pothoulakis, G Hamilton, J Zacherl, G Bischof, ...
The Journal of clinical investigation 95 (5), 2004-2011, 1995
Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum
C Pothoulakis, CP Kelly, MA Joshi, N Gao, CJ O'Keane, I Castagliuolo, ...
Gastroenterology 104 (4), 1108-1115, 1993
Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin
DYM Leung, CP Kelly, M Boguniewicz, C Pothoulakis, JT LaMont, ...
The Journal of pediatrics 118 (4), 633-637, 1991
Intravenous immunoglobulin therapy for severe Clostridium difficile colitis
J Salcedo, S Keates, C Pothoulakis, M Warny, I Castagliuolo, JT LaMont, ...
Gut 41 (3), 366-370, 1997
Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells
I Castagliuolo, JT Lamont, B Qiu, SM Fleming, KR Bhaskar, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 271 (5, 1996
Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum
I Castagliuolo, JT Lamont, ST Nikulasson, C Pothoulakis
Infection and immunity 64 (12), 5225-5232, 1996
Saccharomyces boulardii Stimulates Intestinal Immunoglobulin A Immune Response to Clostridium difficileToxin A in Mice
A Qamar, S Aboudola, M Warny, P Michetti, C Pothoulakis, JT LaMont, ...
Infection and immunity 69 (4), 2762-2765, 2001
CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin.
C Pothoulakis, I Castagliuolo, JT Lamont, A Jaffer, JC O'Keane, ...
Proceedings of the National Academy of Sciences 91 (3), 947-951, 1994
Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life
S Jangi, JT Lamont
Journal of pediatric gastroenterology and nutrition 51 (1), 2-7, 2010
Aspirin prevention of cholesterol gallstone formation in prairie dogs
SP Lee, MC Carey, JT LaMont
Science 211 (4489), 1429-1431, 1981
Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile
PF Levy, BF Smith, JT LaMont
Gastroenterology 87 (2), 270-275, 1984
The system can't perform the operation now. Try again later.
Articles 1–20